Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 9.25
0.00 (0.00%)
Feb 12, 2026, 1:55 PM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 41.09 million as of February 12, 2026. Its market cap has decreased by -15.73% in one year.
Market Cap
41.09M
Enterprise Value
38.41M
Revenue
1.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.25
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 41.09M, a decrease of -63.59%. That is a compound annual growth rate of -21.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 41.09M | 5.71% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4basebio | 91.32M |
| Faron Pharmaceuticals Oy | 66.58M |
| hVIVO | 60.21M |
| Hemogenyx Pharmaceuticals | 57.75M |
| SkinBioTherapeutics | 51.19M |
| Poolbeg Pharma | 32.43M |
| ImmuPharma | 31.72M |
| Arecor Therapeutics | 27.94M |